Lion’s mane (hericium erinaceus)

Mechanism of action

Proposed mechanisms (mainly from preclinical studies): - Neurotrophic activity: some compounds (e.g. erinacines/hericenones) have been associated with increased neurotrophic signaling (NGF and/or BDNF) and modulation of intracellular pathways related to synaptic plasticity. - Neuroprotection: reduction of oxidative stress and neuroinflammation (modulation of cytokines and inflammatory pathways), with possible effects on neuronal integrity and myelin in animal models. - Gut-brain axis: polysaccharides and fungal cell wall components may act as fermentable substrates and modulate the microbiota, with potential downstream effects on systemic inflammation and neurobehavioral signaling. - Metabolism and immunity: beta-glucans and other polysaccharides may influence innate/adaptive immune response and metabolic parameters; the relevance for focus/cognition in humans remains indirect. Note: translation to humans depends on dose, form (mycelium vs fruiting body), standardization, and bioavailability of the active compounds.

Supported benefits

• Improvement in some cognitive domains in adults with mild cognitive impairment (MCI) in small clinical studies (moderate)
• Reduction of anxious-depressive symptoms and improvement in subjective well-being in some populations (e.g. menopausal women) in preliminary trials (limited)
• Support for markers of neuroplasticity/neuroprotection (NGF/BDNF, inflammation, oxidative stress) in preclinical models (emerging)
• Possible support for symptoms of peripheral neuropathy/nerve regeneration in specific contexts (clinical evidence still scarce) (emerging)

Safety & side effects

• Gastrointestinal disturbances (nausea, dyspepsia, diarrhea) in a minority of users
• Skin reactions or itching (possible allergic phenomena)
• Headache or nonspecific sensations of agitation/sedation (anecdotal reports; limited clinical evidence)
• Rarely, hypersensitivity reactions in individuals allergic to mushrooms

FAQ

What is the difference between the fruiting body and mycelium?

The fruiting body is the edible “mushroom” part; mycelium is the vegetative network. Composition may differ: some hericenones are more associated with the fruiting body, while some erinacines are often reported in mycelium extracts. In addition, mycelium grown on grains may contain starches from the substrate, affecting the percentage of beta-glucans and other active compounds.

Are the effects immediate like caffeine?

In clinical trials, outcomes on cognition/mood were typically assessed after weeks. It is not a compound known for a reliable acute effect on focus; any benefit is more often considered subacute/chronic and context-dependent.

Are there human biomarkers confirming an increase in NGF/BDNF?

Much of the evidence on NGF/BDNF comes from cellular/animal models. In humans, biomarker data are limited and not standardized; moreover, peripheral measures (blood) do not always directly reflect levels in the central nervous system.

How should product quality be evaluated?

Useful indicators include: specification of the part used (fruiting body/mycelium), extraction method, declared beta-glucan content with analytical method, any standardization for specific compounds, and third-party testing for contaminants (heavy metals, pesticides, mycotoxins) and species identity.